Trademark: 87232950
Status Date
Monday, September 21, 2020
Filing Date
Thursday, November 10, 2016
Published for Opposition
Tuesday, June 20, 2017
Abandoned Date
Monday, September 21, 2020
9 Computer application software for mobile phones, portable media players, handheld computers, namely, software for use in database management, for use in electronic storage of data, for use as a spreadsheet, and for word processing, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; downloadable software in the nature of a mobile application for use in database management, for use as a spreadsheet, for word processing, for electronic storage of data, in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; computer software for use on mobile and cellular phones in the field of health care and dosing of pharmaceuticals for use in accessing databases and websites in order to provide drug dosage and administration information in the field of lenalidomide; downloadable electronic software for use on mobile and cellular phones, handheld computers in the field of health care and dosing of pharmaceuticals for use in accessing databases and websites in order to provide drug dosage and administration information in the field of lenalidomide; computer application software for mobile phones, portable media players, handheld computers, namely, software for use in database management, for use in electronic storage of data, for use as a spreadsheet, and for word processing, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide
42 Software as a service (SAAS) featuring software for tracking and monitoring medication intake and safety issues pertaining to lenalidomide, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; providing information about the results of clinical trials for pharmaceutical products; providing temporary use of non downloable online software applications containing information on the use of pharmaceutical products and for calculating use of medicine in the field of lenalidomide and safety issues pertaining to lenalidomide; providing temporary use of non-downloadable electronic software for use on mobile and cellular phones, handheld computers in the field of health care and dosing of pharmaceuticals for use in accessing databases and websites in order to provide drug dosage and administration information in the field of lenalidomide and safety issues pertaining to lenalidomide; providing online, non-downloadable computer application software for mobile phones, portable media players, handheld computers, namely, software for use in database management, for use in electronic storage of data, for use as a spreadsheet, and for word processing, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide
Sep 21, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 21, 2020
Abandonment - No Use Statement Filed
Dec 27, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 26, 2019
Extension 5 Granted
Dec 16, 2019
Extension 5 Filed
Dec 26, 2019
Case Assigned To Intent To Use Paralegal
Dec 16, 2019
Teas Extension Received
Jul 8, 2019
Assigned To Examiner
Jun 11, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2019
Extension 4 Granted
Jun 7, 2019
Extension 4 Filed
Jun 7, 2019
Teas Extension Received
Dec 8, 2018
Notice Of Approval Of Extension Request E-Mailed
Dec 6, 2018
Extension 3 Granted
Dec 6, 2018
Extension 3 Filed
Dec 6, 2018
Teas Extension Received
Jul 18, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 16, 2018
Extension 2 Granted
Jul 16, 2018
Extension 2 Filed
Jul 16, 2018
Teas Extension Received
Jan 18, 2018
Notice Of Approval Of Extension Request E-Mailed
Jan 16, 2018
Extension 1 Granted
Jan 16, 2018
Extension 1 Filed
Jan 16, 2018
Teas Extension Received
Aug 15, 2017
Noa E-Mailed - Sou Required From Applicant
Jun 20, 2017
Official Gazette Publication Confirmation E-Mailed
Jun 20, 2017
Published For Opposition
May 31, 2017
Notification Of Notice Of Publication E-Mailed
May 10, 2017
Approved For Pub - Principal Register
Apr 19, 2017
Teas/Email Correspondence Entered
Apr 18, 2017
Correspondence Received In Law Office
Apr 18, 2017
Teas Response To Office Action Received
Jan 13, 2017
Notification Of Non-Final Action E-Mailed
Jan 13, 2017
Non-Final Action E-Mailed
Jan 13, 2017
Non-Final Action Written
Jan 6, 2017
Assigned To Examiner
Nov 17, 2016
Teas Amendment Entered Before Attorney Assigned
Nov 17, 2016
Teas Voluntary Amendment Received
Nov 17, 2016
New Application Office Supplied Data Entered In Tram
Nov 14, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
